Filing Flows › CV Sciences (CVSI) › Q4 2024
CV Sciences (CVSI) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 27, 2025
CV Sciences (CVSI) reported revenue of $3.9M for the fourth quarter 2024 (Q4 2024), +2% from a year earlier and +0.5% from the quarter before. Operating margin was -16.6%, net loss $726K (18.7% of revenue).
CV Sciences, Q4 2024: revenue $3.9M (+2% year over year), operating margin -16.6%, net loss $726K, operating cash flow −$164K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | +0.5% | +2% |
| Operating profit | −$646K | — | — |
| Net earnings | −$726K | — | — |
| Operating cash flow | −$164K | — | — |
What changed
Revenue was $3.9M in Q4 2024, up 2% year over year and roughly flat from the previous quarter.
Gross margin was 43.2%, down 2.7 points from a year earlier. Operating costs exceeded revenue by $646K, an operating margin of -16.6%. Operating expenses fell 12% while revenue rose 2%. The quarter ended with a net loss of $726K, wider than the previous quarter's $456K loss.
Operating cash flow was −$164K. Non-cash charges added back $114K of depreciation and amortization and $104K of share-based compensation. Working capital and other items added $344K. Capital expenditures of $18K exceeded it, leaving free cash flow of −$182K.
Questions
What was CV Sciences' revenue in the fourth quarter 2024?
CV Sciences (CVSI) reported revenue of $3.9M for the fourth quarter 2024 (Q4 2024), +2% from a year earlier and +0.5% from the quarter before.
Was CV Sciences profitable in the fourth quarter 2024?
Operating loss was $646K (-16.6% of revenue) and net loss $726K.
Source: CV Sciences 10-K on SEC EDGAR.